Therefore, we selected B cells isolated from five CLL patients expressing significant levels of Mcl-1 and treated them with selected concentrations of quercetin (10–20 μM), which did not generate any cytotoxicity (data not shown). The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.